Archives of Cardiovascular Diseases
Scope & Guideline
Transforming the future of cardiology with innovative insights.
Introduction
Aims and Scopes
- Clinical Cardiology and Management:
Focused on the diagnosis, treatment, and management of cardiovascular diseases, including acute and chronic conditions such as coronary artery disease, heart failure, and arrhythmias. - Cardiovascular Imaging and Diagnostics:
Dedicated to advancements in imaging techniques and diagnostic methodologies, including echocardiography, cardiac magnetic resonance imaging, and novel biomarker assessments. - Interventional Cardiology:
Covers research related to catheter-based interventions, transcatheter aortic valve implantation (TAVI), and other minimally invasive procedures for treating cardiovascular diseases. - Cardiovascular Pharmacotherapy:
Explores the use of pharmacological agents in managing cardiovascular conditions, including the efficacy and safety of new drugs and treatment regimens. - Epidemiology and Public Health:
Investigates the epidemiological trends, risk factors, and public health implications of cardiovascular diseases, contributing to a better understanding of disease prevention and management strategies. - Innovative Therapies and Technologies:
Focuses on the development and evaluation of innovative therapies, including gene therapy, stem cell treatments, and emerging technologies in cardiovascular care.
Trending and Emerging
- Remote Monitoring and Telemedicine:
With the rise of digital health technologies, there is an increasing focus on remote monitoring of patients with cardiovascular diseases, particularly in the context of managing chronic conditions and during the COVID-19 pandemic. - Artificial Intelligence and Machine Learning:
The application of AI and machine learning in predicting cardiovascular events and outcomes is gaining prominence, showcasing the integration of advanced analytics in clinical cardiology. - Personalized and Precision Medicine:
Emerging research is emphasizing personalized treatment approaches based on genetic, biomarker, and patient-specific data, aimed at optimizing therapeutic outcomes in cardiovascular care. - Cardiovascular Outcomes in Cancer Patients:
Research investigating the intersection between cardiovascular health and cancer management is becoming increasingly relevant, particularly as survival rates improve and long-term cardiovascular risks are recognized. - Heart Failure with Preserved Ejection Fraction (HFpEF):
The focus on HFpEF is growing, with studies exploring its pathophysiology, management strategies, and the impact of comorbidities, reflecting an urgent need to address this complex condition.
Declining or Waning
- Traditional Risk Factor Studies:
Research focusing solely on traditional cardiovascular risk factors, such as hypertension and hyperlipidemia, has seen a decline as newer studies explore more complex interactions and novel risk factors. - Historical Perspectives on Cardiovascular Diseases:
Papers that provide historical overviews or retrospective analyses of cardiovascular disease management are less frequent, possibly overshadowed by contemporary and forward-looking research. - Single-Center Studies:
The prevalence of single-center studies appears to be waning as multicenter and collaborative research efforts gain traction, providing more robust and generalizable findings. - Basic Science Research:
There is a noticeable decrease in publications focused solely on basic science and laboratory studies, as the emphasis shifts towards translational research that bridges laboratory findings with clinical applications. - Non-Cardiovascular Comorbidity Research:
Research examining comorbidities that are not directly related to cardiovascular outcomes has diminished, with a stronger focus on the interplay between cardiovascular diseases and other systemic conditions.
Similar Journals
Kardiologia Polska
Bridging Knowledge and Practice in CardiologyKardiologia Polska, the esteemed journal of the Polish Cardiac Society, has established itself as a vital resource in the field of cardiology and cardiovascular medicine since its inception in 1954. With an ISSN of 0022-9032 and an E-ISSN of 1897-4279, this journal serves as a platform for groundbreaking research and scholarly articles that contribute to the advancement of heart health. Although currently not an open access journal, it remains an essential reference for practitioners and researchers seeking to stay abreast of the latest developments in cardiovascular science. The journal reflects its scholarly depth through a Category Quartile of Q3 and a commendable Scopus ranking at the 48th percentile in its field. Published primarily in Poland, it caters to a global audience eager to explore comprehensive studies spanning clinical cardiology, innovative therapeutic approaches, and emerging cardiovascular trends. Join a thriving academic community by engaging with the invaluable insights and research contributions found within the pages of Kardiologia Polska.
Cardiology Journal
Championing open access to vital cardiology research.Cardiology Journal, published by VIA MEDICA, stands as a prominent resource in the field of cardiology and cardiovascular medicine, with an ISSN of 1897-5593 and an E-ISSN of 1898-018X. Recognized for its Open Access model established since 1994, this journal facilitates widespread dissemination of critical research findings, allowing practitioners and researchers globally to access valuable insights without barriers. Based in Poland, with an address at UL SWIETOKRZYSKA 73, 80-180 GDANSK, it has achieved a respectable Q2 classification in 2023 for both Cardiology and Miscellaneous Medicine categories, reflecting its influence and quality within the scholarly community. With a Scopus ranking placing it at #117 out of 387 in Cardiology, it lies within the 69th percentile, underpinning its commitment to advancing knowledge in cardiovascular health. The journal’s converged years extending from 2006 to 2024 ensure it captures ongoing developments in a rapidly evolving field. As such, the Cardiology Journal serves as an indispensable platform for researchers, professionals, and students dedicated to exploring the frontiers of cardiac science and improving patient care.
TEXAS HEART INSTITUTE JOURNAL
Exploring Innovations in Heart Care and Research.TEXAS HEART INSTITUTE JOURNAL, published by the renowned Texas Heart Institute, stands as a pivotal resource in the field of cardiology and cardiovascular medicine. With a history spanning over four decades since its establishment in 1982, this journal addresses a wide range of topics within its scope, including clinical studies, innovative treatments, and groundbreaking research in heart health. Despite its Q3 ranking in both Cardiology and Cardiovascular Medicine, the journal is committed to fostering advancement in medical knowledge and practice, providing an essential platform for healthcare professionals and researchers alike. While currently lacking open access, the journal is recognized for its contributions to the field, aiming to illuminate critical healthcare discussions and promote the exchange of ideas. For those interested in staying at the forefront of cardiovascular research, TEXAS HEART INSTITUTE JOURNAL offers invaluable insights and the latest developments shaping the future of heart care.
Journal of Cardiovascular Development and Disease
Fostering collaboration in the evolution of cardiac science.Journal of Cardiovascular Development and Disease, an esteemed publication by MDPI, has been a dedicated platform for disseminating cutting-edge research since its inception in 2014. Based in Switzerland, this Open Access journal not only provides unrestricted access to its content but also fosters global collaboration among scholars focusing on cardiovascular health and disease development. With an impressive focus classified as Q1 in Pharmacology, Toxicology and Pharmaceutics for 2023, it attracts a diverse range of interdisciplinary research, supporting advancements in pharmacological applications relevant to cardiac conditions. The journal's ongoing convergence through 2024 highlights its commitment to the evolving landscape of cardiovascular research, making it a vital resource for researchers, professionals, and students alike who are keen to contribute to and learn from significant developments in this critical field.
Anatolian Journal of Cardiology
Fostering Cardiovascular Excellence Since 2001.The Anatolian Journal of Cardiology, published by KARE PUBL, stands as a vital resource in the field of Cardiology and Cardiovascular Medicine. With an ISSN of 2149-2263 and E-ISSN 2149-2271, this Open Access journal has been fostering the dissemination of critical research since 2001, ensuring that high-quality content is freely available to a global audience. Based in Turkey, the journal aims to bridge gaps in cardiological knowledge through rigorous peer-reviewed articles that span a wide range of topics, from innovative clinical practices to groundbreaking research findings. While its current ranking places it in the Q3 category of cardiology journals, the Anatolian Journal of Cardiology continues to strive towards enhancing its impact, currently holding a Scopus rank of 236 out of 387. Researchers, practitioners, and students alike will find this journal an essential platform for keeping abreast of the latest developments in cardiovascular health.
Journal fur Kardiologie
Advancing Cardiovascular Knowledge, One Study at a Time.The Journal fur Kardiologie, published by KRAUSE & PACHERNEGG GMBH, is a pivotal resource in the field of Cardiology and Cardiovascular Medicine. With an ISSN of 1024-0098 and an E-ISSN of 1680-936X, this journal has played a significant role in disseminating valuable research and clinical studies from 1998 until its coverage discontinuation in Scopus in 2017. Despite its Scopus rank being relatively low at #316/324 in its category, it continues to serve as a platform for emerging cardiology research. The journal’s scope encompasses various aspects of cardiovascular health, providing insights that are crucial for researchers, professionals, and students alike seeking to advance their knowledge and practice in cardiology. While the journal is not open access, its contributions to the field are essential for those looking to stay informed about the latest developments in cardiovascular medicine.
Revista Portuguesa de Cardiologia
Empowering the fight against heart disease through open access research.Revista Portuguesa de Cardiologia, published by Elsevier España SLU, stands as a pivotal resource in the realm of Cardiology and Cardiovascular Medicine. With its origins tracing back to 1970, this journal has cultivated a robust academic presence, achieving a 2023 Q3 ranking in its category, and currently holding a position of #220 out of 387 on the Scopus rankings, placing it within the 43rd percentile of its field. This open access journal, available since 2011, aims to disseminate high-quality research and insights relevant to contemporary cardiovascular issues. Its commitment to accessibility and knowledge exchange enhances its importance for clinicians, researchers, and students alike, fostering a more informed community in the fight against cardiovascular diseases. Operating from its base in Barcelona, Spain, the journal welcomes contributions that further the understanding and treatment of heart conditions, contributing significantly to the advancement of cardiovascular health.
REVISTA ESPANOLA DE CARDIOLOGIA
Fostering Excellence in Cardiovascular ResearchREVISTA ESPANOLA DE CARDIOLOGIA is a premier journal dedicated to the dynamic field of cardiology, published by EDICIONES DOYMA S A in Barcelona, Spain. With an impressive Q1 status in the Medicine (miscellaneous) category for 2023, this journal is recognized for its significant contributions to cardiovascular research, evidenced by its rank of #61 out of 387 in the Scopus database, placing it within the top 16% of journals in its field. Covering a broad range of topics within cardiology, the journal aims to disseminate high-quality research, clinical studies, and educational content, fostering knowledge sharing among researchers, clinicians, and students alike. While it does not currently offer open access, the journal maintains a commitment to advancing cardiovascular health through rigorous peer-reviewed articles. With a publication history that spans from 2013 to 2024, REVISTA ESPANOLA DE CARDIOLOGIA is an essential resource for those seeking to stay at the forefront of cardiology advancements and practices.
Indian Heart Journal
Elevating Cardiovascular Research to New HeightsIndian Heart Journal, published by Elsevier, is a distinguished peer-reviewed journal dedicated to the field of cardiology and cardiovascular medicine. Founded in 1961, this journal has been a pivotal resource for researchers, healthcare professionals, and students, providing a platform for innovative studies and insights into heart health. The journal transitioned to an Open Access model in 2013, ensuring widespread dissemination of vital research findings to enhance global understanding of cardiovascular diseases. Ranked in the Q3 category for Cardiology and Cardiovascular Medicine in 2023, it holds a reputable position in the medical community, with a Scopus rank of #222 out of 387 journals in the same field, placing it in the 42nd percentile. The Indian Heart Journal strives to foster advances in clinical practice and research while addressing the unique cardiac health challenges faced in India and beyond.
Journal of the Saudi Heart Association
Fostering Innovation in Cardiology for Global ImpactThe Journal of the Saudi Heart Association is a prominent scholarly publication dedicated to advancing knowledge in the fields of cardiology and cardiovascular medicine. Published by DIGITAL COMMONS BEPRESS, this open-access journal has been serving the global community since 2009, providing a vital platform for researchers, practitioners, and students interested in the latest developments in heart health and disease management. With an ISSN of 1016-7315 and a growing repository of knowledge alongside an E-ISSN of 2212-5043, the journal showcases an array of peer-reviewed articles that contribute to the understanding of cardiovascular conditions. Although categorized in the Q4 quartile for 2023, it remains committed to offering valuable insights, particularly within the constraints of the 29th percentile rank specified by Scopus. As the journal converges towards 2024, it continues to foster collaboration, innovation, and inquiry within the Saudi Arabian and international medical communities.